Results 231 to 240 of about 28,388 (258)

Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2022
Ngoc-Yen T. Pham, Christos Argyropoulos, Nhan Dinh   +2 more
openaire   +1 more source

Dipeptidyl peptidase 4 inhibitors

Reactions Weekly
openaire   +2 more sources

Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials

International Journal of Cardiology, 2016
, Nathorn Chaiyakunapruk, Surakit Nathisuwan   +2 more
exaly  

Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Clinical Therapeutics, 2017
Linong Ji, Yang Xu, Siyan Zhan
exaly  

Dipeptidyl peptidase‐4 inhibitors and cardiovascular safety

Medical Journal of Australia, 2014
openaire   +2 more sources

The Unique Properties of Dipeptidyl-peptidase IV (DPP IV I CD26) and the Therapeutic Potential of DPP IV Inhibitors

Current Medicinal Chemistry, 1999
Koen Augustyns, F Goossens, C Durinx
exaly  

Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
Carl Crysler
exaly  

Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus

Circulation: Heart Failure, 2017
Kwan-Woo Lee, Hae Jin Kim, Young-Gun Kim   +2 more
exaly  

DIPEPTIDYL PEPTIDASE-4 INHIBITOR

2011
TOMINAGA YUJI, YOKOTA SHINICHI, TANAKA HOZUMI, KISHIDA HIDEYUKI, KITAGAWA MASAYASU, TACHI HIROSHI, OTA TORU   +6 more
openaire   +4 more sources

Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland

Journal of the American Academy of Dermatology, 2018
Simone Cazzaniga, Marie Aleth Richard, René Valero   +2 more
exaly